EBS Stock Summary and Trading Ideas (Emergent Biosolutions | NYSE:EBS)

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

Emergent Biosolutions trades on the NYSE stock market under the symbol EBS.

As of April 23, 2024, EBS stock price climbed to $2.29 with 846,804 million shares trading.

EBS has a beta of 2.13, meaning it tends to be more sensitive to market movements. EBS has a correlation of 0.07 to the broad based SPY ETF.

EBS has a market cap of $118.82 million. This is considered a Micro Cap stock.

Last quarter Emergent Biosolutions reported $277 million in Revenue and -$.77 earnings per share. This fell short of revenue expectation by $-17 million and missed earnings estimates by -$.58.

In the last 3 years, EBS stock traded as high as $68.03 and as low as $1.42.

The top ETF exchange traded funds that EBS belongs to (by Net Assets): FNDA, VTI, IWM, VXF, PRFZ.

EBS stock has underperformed the market in the last year with a return of -77.9%, while SPY returned +24.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in EBS shares. However, EBS has outperformed the market in the last 3 month and 2 week periods, returning +16.2% and -1.3%, while SPY returned +4.9% and -2.5%, respectively. This indicates EBS has been having a stronger performance recently.

EBS support price is $2.04 and resistance is $2.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EBS stock will trade within this expected range on the day.